Reported Consolidated quarterly numbers for Gennex Laboratories are:Net Sales at Rs 19.11 crore in September 2022 up 35% from Rs. 14.16 crore in September 2021.
Quarterly Net Profit at Rs. 1.05 crore in September 2022 down 5.41% from Rs. 1.11 crore in September 2021.
EBITDA stands at Rs. 1.86 crore in September 2022 down 4.12% from Rs. 1.94 crore in September 2021.
Gennex Labs EPS has decreased to Rs. 0.08 in September 2022 from Rs. 0.09 in September 2021.
| Gennex Labs shares closed at 6.51 on November 15, 2022 (BSE) and has given -8.44% returns over the last 6 months and -10.33% over the last 12 months. |
| Gennex Laboratories | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'22 | Jun'22 | Sep'21 | | Net Sales/Income from operations | 19.11 | 13.94 | 14.16 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 19.11 | 13.94 | 14.16 | | EXPENDITURE | | Consumption of Raw Materials | 10.97 | 12.40 | 8.71 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 1.82 | -4.23 | -0.80 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.91 | 1.86 | 1.82 | | Depreciation | 0.10 | 0.18 | 0.20 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.08 | 3.03 | 2.62 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 1.25 | 0.70 | 1.61 | | Other Income | 0.51 | 0.57 | 0.13 | | P/L Before Int., Excpt. Items & Tax | 1.76 | 1.27 | 1.74 | | Interest | 0.36 | 0.26 | 0.24 | | P/L Before Exceptional Items & Tax | 1.40 | 1.01 | 1.50 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 1.40 | 1.01 | 1.50 | | Tax | 0.35 | 0.25 | 0.40 | | P/L After Tax from Ordinary Activities | 1.05 | 0.75 | 1.11 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.05 | 0.75 | 1.11 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 1.05 | 0.75 | 1.11 | | Equity Share Capital | 12.65 | 12.65 | 12.65 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.08 | 0.06 | 0.09 | | Diluted EPS | 0.08 | 0.06 | 0.09 | | EPS After Extra Ordinary | | Basic EPS | 0.08 | 0.06 | 0.09 | | Diluted EPS | 0.08 | 0.06 | 0.09 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|